Page 39 - Healthcare

Medicine sale by dealers to retailers hit Rs 1.40 trn in Apr-Dec: Mandaviya

The total sale of medicines by stockists/dealers to retailers in India stood at over Rs 1.40 lakh crore during the April-December period, Rajya Sabha was informed on Tuesday. In a written reply to a query, Union Minister of Chemicals and Fertilisers Mansukh Mandaviya laid a statement on the table of the Upper House stating no separate data is, however, maintained regarding consumption of generic medicines in the country. During the April-December 2022 period, the total sales of medicines by stockists or dealers to retailers was at Rs 1,40,865.31 crore. In 2021-2022, it was at Rs 1,69,234.82 crore while the same stood at Rs 1,47,586.41 crore in 2020-2021, as per the statement. The Department of Pharmaceuticals has taken various steps for increasing the production of drugs in the country and encourage domestic manufacturing of pharmaceutical drugs, including PLI scheme for manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical ...

Online medical consultations in smaller cities grew 87% last calendar year

Lybrate study reports 65% spike in online appointments by women in 2022 over 2021; gastroenterology and ENT top list of consulted specialities

Karnataka: CM Bommai to inaugurate 108 Namma Clinics in BBMP limits today

Chief Minister Basavaraj Bommai would opening as many as 108 Namma Clinics on Tuesday to provide universal and comprehensive Primary Healthcare to common people

Procter & Gamble's net profit dips by 2% to Rs 207 cr in December quarter

Procter & Gamble Hygiene and Health Care on Monday said its net profit declined 2 per cent to Rs 207 crore for the October-December quarter on account of commodity cost inflation. The company, which follows the July-June financial year, had posted a net profit of Rs 212 crore in the same period of last fiscal. Revenue from operations rose to Rs 1,137 crore in the period under review as against Rs 1,092 crore in the year-ago period, Procter & Gamble said in a statement. "Despite external headwinds and macro-economic environment, we delivered a resilient performance as this quarter recorded sequential progress across topline and bottom line," Procter & Gamble Hygiene and Health Care Managing Director LV Vaidyanathan said. This has been possible behind the company's integrated growth strategies of a focused product portfolio, superiority, productivity, constructive disruption, and an agile and accountable organisation, it added. The board of the company on Monday declared an .

India accounts for 57% of leprosy cases globally: Dr Lobo at book launch

Dr Lobo shared his thoughts on leprosy at the launch even of his book titled 'Dr S K Noordeen: Architect of the Global Leprosy Elimination Program'

India accounts for 57% of leprosy cases globally: Dr Lobo at book launch

Dr Lobo shared his thoughts on leprosy at the launch event of his book titled 'Dr S K Noordeen: Architect of the Global Leprosy Elimination Program'

For insurance cover against cancer, maintain high sum for hospitalisation

February 4 is World Cancer Day: here is advice on how meet ancillary expenses in treating disease

Govt needs to complement intent with concrete roadmap to boost tourism

In order to attract more international tourists, India must increase investment and leverage public-private partnership models in healthcare at a faster pace

On the agenda: Budget focuses on quality and reach of healthcare in India

It is hoped there is both a short- and long-term vision to make India a leader in the pharmaceutical sector beyond generic drug manufacture

More funds for social sector in Budget: Pain points & what's on offer

Health spending dipped in 2022-23

Union Budget 2023: What health and nutrition sectors want this year

Here's what voices from healthcare & nutrition sector are expecting from Union Budget

Focus mustn't waver, we must continue to invest in health: K Srinath Reddy

We have to create a multi-layered, multi-skilled health workforce. This is good even from the point of view of employment generation, says PHFI founder

US FDA joins global regulators probing tainted overseas cough syrup

The agency seeks more information about the specific raw materials used and whether they were obtained from any of the same suppliers

Aam Aadmi clinics in Punjab are political gimmickry: BJP's Tarun Chugh

Chugh claimed that the entire state "knows that the health dispensaries and mini hospitals are being converted into Aam Aadmi clinics for political reasons"

Healtech startup Innovaccer lays off 15% employees amid structural rejig

An Innovaccer spokesperson said that the company's priority is to fully support its impacted employees, which includes offering them a generous package

Abbott faces criminal investigation over baby formula, says report

The Michigan plant came to national attention in 2022 after FDA, while fielding reports of infants sickened by formula produced there, found strikingly unsanitary co

Digital healthcare provider MediBuddy lays off around 200 employees

MediBuddy, an end-to-end digital healthcare platform in India, has laid off 8 per cent of its workforce, around 200 people, across all departments as a restructuring exercise

Medical value travel key to address disparities in healthcare system: Govt

One of the highlights of three days meeting was a side event on Medical Value Travel

Union Budget 2023: Experts don't expect surprises in social sector outlay

While experts believe that provision for various social schemes may go up, the sector is unlikely to see any major announcements

Budget wishlist: Pharma, healthcare industries seek simplified regulations

Fortis Healthcare MD & CEO Ashutosh Raghuvanshi said increased policy support is required to encourage, facilitate medical value travel to India